Cargando…

Pulmonary tularaemia: a differential diagnosis to lung cancer

BACKGROUND: Pulmonary manifestations of tularaemia are reported to be infrequent in previous publications. During 2016, we noticed an increase in the number of hospitalised patients with pulmonary tularaemia in Eastern Norway. We aimed to investigate primary pulmonary tularaemia in Eastern Norway in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kravdal, Astrid, Stubhaug, Øystein Olav, Wågø, Anne Grete, Steien Sætereng, Magnus, Amundsen, Dag, Piekuviene, Ruta, Kristiansen, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322898/
https://www.ncbi.nlm.nih.gov/pubmed/32613015
http://dx.doi.org/10.1183/23120541.00093-2019
_version_ 1783551730941689856
author Kravdal, Astrid
Stubhaug, Øystein Olav
Wågø, Anne Grete
Steien Sætereng, Magnus
Amundsen, Dag
Piekuviene, Ruta
Kristiansen, Annette
author_facet Kravdal, Astrid
Stubhaug, Øystein Olav
Wågø, Anne Grete
Steien Sætereng, Magnus
Amundsen, Dag
Piekuviene, Ruta
Kristiansen, Annette
author_sort Kravdal, Astrid
collection PubMed
description BACKGROUND: Pulmonary manifestations of tularaemia are reported to be infrequent in previous publications. During 2016, we noticed an increase in the number of hospitalised patients with pulmonary tularaemia in Eastern Norway. We aimed to investigate primary pulmonary tularaemia in Eastern Norway in terms of symptoms, radiological and microbiological findings, incidence and risk exposure. METHODS: A retrospective analysis of consecutive primary pulmonary tularaemia cases from 2016 until 2018 was conducted. RESULTS: From 1 September, 2016 until 31 December, 2018, 22 patients were diagnosed with primary pulmonary tularaemia at Innlandet Hospital Trust, representing 48% of all reported tularaemia cases in the region. A peak annual incidence of 3.4 in 100 000 was found in 2017. All 22 patients lived in, or had recently visited, rural areas. Eighteen patients reported risk exposure for tularaemia, such as wood chopping, outdoor activities and farming prior to symptom onset. All patients experienced fever, and 19 patients had respiratory symptoms. Ten patients were in spontaneous recovery at diagnosis. All patients had a chest computed tomography scan. Overall, 19 patients had pulmonary lesions and 18 had enlarged intrathoracic lymph nodes. The computed tomography images were described as suspicious of malignancy in 17 patients. CONCLUSION: Pulmonary manifestations in tularaemia occurred more frequently in our region than expected from previous reports. Although all patients had symptoms consistent with infection, the majority were primarily investigated considering lung cancer due to the radiology report. In endemic areas, pulmonary tularaemia may be an important differential diagnosis to lung cancer.
format Online
Article
Text
id pubmed-7322898
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-73228982020-06-30 Pulmonary tularaemia: a differential diagnosis to lung cancer Kravdal, Astrid Stubhaug, Øystein Olav Wågø, Anne Grete Steien Sætereng, Magnus Amundsen, Dag Piekuviene, Ruta Kristiansen, Annette ERJ Open Res Original Articles BACKGROUND: Pulmonary manifestations of tularaemia are reported to be infrequent in previous publications. During 2016, we noticed an increase in the number of hospitalised patients with pulmonary tularaemia in Eastern Norway. We aimed to investigate primary pulmonary tularaemia in Eastern Norway in terms of symptoms, radiological and microbiological findings, incidence and risk exposure. METHODS: A retrospective analysis of consecutive primary pulmonary tularaemia cases from 2016 until 2018 was conducted. RESULTS: From 1 September, 2016 until 31 December, 2018, 22 patients were diagnosed with primary pulmonary tularaemia at Innlandet Hospital Trust, representing 48% of all reported tularaemia cases in the region. A peak annual incidence of 3.4 in 100 000 was found in 2017. All 22 patients lived in, or had recently visited, rural areas. Eighteen patients reported risk exposure for tularaemia, such as wood chopping, outdoor activities and farming prior to symptom onset. All patients experienced fever, and 19 patients had respiratory symptoms. Ten patients were in spontaneous recovery at diagnosis. All patients had a chest computed tomography scan. Overall, 19 patients had pulmonary lesions and 18 had enlarged intrathoracic lymph nodes. The computed tomography images were described as suspicious of malignancy in 17 patients. CONCLUSION: Pulmonary manifestations in tularaemia occurred more frequently in our region than expected from previous reports. Although all patients had symptoms consistent with infection, the majority were primarily investigated considering lung cancer due to the radiology report. In endemic areas, pulmonary tularaemia may be an important differential diagnosis to lung cancer. European Respiratory Society 2020-06-29 /pmc/articles/PMC7322898/ /pubmed/32613015 http://dx.doi.org/10.1183/23120541.00093-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Articles
Kravdal, Astrid
Stubhaug, Øystein Olav
Wågø, Anne Grete
Steien Sætereng, Magnus
Amundsen, Dag
Piekuviene, Ruta
Kristiansen, Annette
Pulmonary tularaemia: a differential diagnosis to lung cancer
title Pulmonary tularaemia: a differential diagnosis to lung cancer
title_full Pulmonary tularaemia: a differential diagnosis to lung cancer
title_fullStr Pulmonary tularaemia: a differential diagnosis to lung cancer
title_full_unstemmed Pulmonary tularaemia: a differential diagnosis to lung cancer
title_short Pulmonary tularaemia: a differential diagnosis to lung cancer
title_sort pulmonary tularaemia: a differential diagnosis to lung cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322898/
https://www.ncbi.nlm.nih.gov/pubmed/32613015
http://dx.doi.org/10.1183/23120541.00093-2019
work_keys_str_mv AT kravdalastrid pulmonarytularaemiaadifferentialdiagnosistolungcancer
AT stubhaugøysteinolav pulmonarytularaemiaadifferentialdiagnosistolungcancer
AT wagøannegrete pulmonarytularaemiaadifferentialdiagnosistolungcancer
AT steiensæterengmagnus pulmonarytularaemiaadifferentialdiagnosistolungcancer
AT amundsendag pulmonarytularaemiaadifferentialdiagnosistolungcancer
AT piekuvieneruta pulmonarytularaemiaadifferentialdiagnosistolungcancer
AT kristiansenannette pulmonarytularaemiaadifferentialdiagnosistolungcancer